Ammar, Usama M. Abdel-Maksoud, Mohammed S. Ali, Eslam M. H. Mersal, Karim, I Yoo, Kyung Ho Oh, Chang-Hyun 2024-01-19T17:04:00Z 2024-01-19T17:04:00Z 2022-01-10 2020-07 0045-2068 https://pubs.kist.re.kr/handle/201004/118430 English ACADEMIC PRESS INC ELSEVIER SCIENCE BIOLOGICAL EVALUATION MALIGNANT-MELANOMA BRAF MUTATIONS ENCORAFENIB VEMURAFENIB GROWTH AGENTS KINASE Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening Article 10.1016/j.bioorg.2020.103967 1 BIOORGANIC CHEMISTRY, v.100 BIOORGANIC CHEMISTRY 100 scie scopus 000540960000003 Biochemistry & Molecular Biology Chemistry, Organic Biochemistry & Molecular Biology Chemistry Article BIOLOGICAL EVALUATION MALIGNANT-MELANOMA BRAF MUTATIONS ENCORAFENIB VEMURAFENIB GROWTH AGENTS KINASE anti cancer B-Raf V600E Imidazo[2,1-b]thiazole In silico screening